Patrick Aebischer

Patrick Aebischer, Vice Chairman and Lead Independent Director of PolyPeptide Group, is a Swiss citizen born in 1954. Mr. Aebischer is a Professor of Neurosciences at École Polytechnique Fédérale de Lausanne (EFPL), Lausanne. He serves as a member of the Board of Directors of Nestlé AG, Cham (since 2015) and Logitech International SA, Apples (since 2016) and as Chairman of the Novartis Venture Fund (since 2014), Amazentis SA, Ecublens (since 2008), and Arctos Medical AG, Bern (since 2019). Mr. Aebischer further serves as senior partner of ND Capital, Fund-III (since 2017). Between 2008 and 2020, Mr. Aebischer served as a member of the Board of Directors of Lonza Group AG, Basel. Further, he was a founding scientist and member of the Board of Directors of CytoTherapeutics Inc. (between 1989 and 1999) and Modex Therapeutiques Inc. Between 2000 and 2016, he was president of EPFL and between 2004 and 2016, he served as a member of the Board of the Swiss Federal Institute of Technology (ETH). Mr. Aebischer holds a Doctorate degree in Medicine from the University of Geneva as well as four Honorary Doctorates from Universities worldwide.